(Q30849119)

27 June 2017

title

Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA. (English)

1 reference

multicenter clinical trial

27 June 2017

main subject

0 references

1 reference

A Seyedroudbari

1

1 reference

27 June 2017

E R Kessler

2

1 reference

27 June 2017

A N Mooss

3

1 reference

27 June 2017

R L Wundeman

4

1 reference

27 June 2017

M Bala

5

1 reference

27 June 2017

D E Hilleman

6

1 reference

27 June 2017

publication date

1 April 2000

1 reference

Journal of Thrombosis and Thrombolysis

27 June 2017

published in

1 reference

27 June 2017

volume

9

1 reference

27 June 2017

issue

3

1 reference

27 June 2017

page(s)

303-308

1 reference

Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myoca

27 June 2017

cites work

1 reference

12 December 2020

Use of alteplase for myocardial infarction in two community hospitals

1 reference

12 December 2020

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

12 December 2020

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

12 December 2020

A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomes

1 reference

12 December 2020

Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Virginia Thrombolytic Study Group

1 reference

12 December 2020

Thrombolysis for acute myocardial infarction

1 reference

12 December 2020

Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.

1 reference

12 December 2020

An analysis of time delays preceding thrombolysis for acute myocardial infarction

1 reference

12 December 2020

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018797411812

1 reference

Dimensions Publication ID

27 June 2017

1018742019

0 references

1 reference